Real-time enrollment status for this egfr inhibitor rash clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:40 AM UTC
| NCT Number | NCT06830863 |
| Recruiting Status | Recruiting |
| Condition | EGFR inhibitor rash |
| Phase | Clinical Trial |
| Target Enrollment | 32 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Azitra Inc. |
| Last Updated on CT.gov | February 11, 2026 (Feb 11, 2026) |
As of April 17, 2026: Clinical trial NCT06830863 is currently recruiting participants. This clinical trial study for egfr inhibitor rash is actively seeking new participants at 3 locations across the United States. The study is sponsored by Azitra Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06830863 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06830863 was last updated Feb 11, 2026 (February 11, 2026). HelloStudys verifies this status automatically.